KRAS G12C Drug Development: Discrimination between Switch II Pocket Configurations Using Hydrogen/Deuterium-Exchange Mass Spectrometry
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Sep 01, 2017
- Source ID
- 10.1016/j.str.2017.07.003
Entities
People
- David W Scott
- Jia Grace Lu
- John R. Engen
- Kenneth D Westover
- Lianbo Li
- Mei Zeng
- Nathanael Gray
- Rane A. Harrison
- Sudershan Gondi
Organizations
- Astellas Pharma (United States)
- National Institutes of Health
- Office of Biological and Environmental Research
- United States Department of Defense